## HWM: Howmet Aerospace Inc. - XLI: Industrials

### Executive Summary

VALUE thesis: PEG 0.80 indicates fundamental undervaluation. Quality metrics strong (ROE 30%, ROA 11%). Consistent execution (4/4 quarters beat estimates).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($182.32)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 3
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Does Howmet Aerospace (NYSE:HWM) Have A Healthy Balance Sheet?**
- Source: 富途牛牛 | 20251208T140700 | Bullish | Relevance: 98%
- Howmet Aerospace Inc. (NYSE:HWM) has a healthy balance sheet, with its net debt at 1.1 times its EBITDA and its EBIT covering interest expenses 14.4 times over. The company's debt decreased to US$3.19 billion as of September 2025, and its EBIT grew by 31% over the last year. Howmet Aerospace also generated robust free cash flow, equating to 65% of its EBIT, indicating a strong ability to manage and reduce its debt.

**2. Is Howmet Aerospace stock outperforming the Dow?**
- Source: MSN | 20251206T160757 | Neutral | Relevance: 97%
-  The provided content is an empty MSN page, so no meaningful summary can be generated. The article title asks if Howmet Aerospace stock is outperforming the Dow, but no data or discussion is present.

**3. Zim weighs MBO. Worth the bother for other carriers?**
- Source: The Loadstar | 20251206T053033 | Neutral | Relevance: 64%
- Zim's CEO, Eli Glickman, is reportedly attempting a management buyout (MBO) with outside investors, offering $20 per share for the company. This move has prompted Zim shareholders to engage Evercore for advice and has sparked rumors of an opportunistic offer from Maersk. The article explores the reasons why potential buyers might be interested or disinterested in acquiring Zim amidst a challenging container market.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 2, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-14 | B of A Securiti | $250 | $215 | +16% |
| 2025-11-10 | JP Morgan | $227 | $190 | +19% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-14 | B of A Securiti | main | Buy |
| 2025-11-10 | JP Morgan | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 3 ($0.07M) |
| Sells | 1 ($0.12M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 58.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 2 |

**Top Holders:**
- JPMORGAN CHASE & CO: 14.3% (+80.7%)
- Vanguard Group Inc: 12.2% (+1.4%)
- Blackrock Inc.: 12.0% (+4.5%)
- State Street Corpora: 4.5% (+1.6%)
- FMR, LLC: 4.0% (+2.4%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.80 indicates undervaluation relative to growth. Forward P/E 43.7x stretched relative to 20% growth. Quality metrics strong (ROE 30%, ROA 11%, margin 18%). Balance sheet: strong liquidity (2.4x). Analyst sentiment positive (2 raises, avg +18%). Institutional flow bullish (7 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $77.9B |
| Beta | 1.32 |
| 52W Range | $105.04 - $211.95 |
| Short Interest | 3.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.80 |
| Forward P/E | 43.7 |
| Current P/E | 52.4 |
| YoY Growth | 20.0% |
| EPS Direction | STABLE |

### Technicals

MRS_20 stable at -5.4% (minimal 5-day change). Below STRENGTH zone by 9.4pp (needs >4.0% for momentum thesis). AM_20 at -3.4% indicates price below own 20MA trend. Underperforming sector by 4.7pp, stock-specific weakness. Long-term uptrend intact (above SMA200 at 1.14x) but short-term weakness (below SMA20). MACD histogram bearish (-1.40), momentum weakening. RSI neutral at 42.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -5.40% (CS: 12) | Weak |
| RSI_14 | 42.3 | Neutral |
| MACD Histogram | -1.40 | Bearish |
| vs SMA20 | 0.966x | Below |
| vs SMA50 | 0.978x | Below |
| vs SMA200 | 1.136x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $193.64
- **Stop Loss:** $182.32 (5.8% risk)
- **Target:** $216.28 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 44
- **Position Value:** $8,520.16
- **Portfolio %:** 8.52%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

### Earnings

**Next:** 2026-02-12 (Est: $0.96)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.91 | $0.95 | +4.5% |
| 2025Q2 | $0.87 | $0.91 | +4.2% |
| 2025Q1 | $0.78 | $0.86 | +10.7% |
| 2024Q4 | $0.72 | $0.74 | +2.8% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*